(Q43144926)

14 November 2017

title

Schizophrenia severity and clozapine treatment outcome association with oxytocinergic genes (English)

1 reference

14 November 2017

1 reference

1

1 reference

14 November 2017

4

Jeffrey A Lieberman

1 reference

14 November 2017

3

0 references

James L. Kennedy

series ordinal

5

object named as

James L Kennedy

1 reference

14 November 2017

Vincenzo de Luca

2

1 reference

14 November 2017

publication date

3 March 2010

1 reference

The International Journal of Neuropsychopharmacology

14 November 2017

published in

1 reference

14 November 2017

volume

13

1 reference

14 November 2017

issue

6

1 reference

14 November 2017

page(s)

793-798

1 reference

Other method for adjustment of multiple testing exists

14 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000167

7 January 2021

Haploview: analysis and visualization of LD and haplotype maps

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000167

7 January 2021

Vasopressin--oxytocin in cerebrospinal fluid of schizophrenic patients and normal controls.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000167

7 January 2021

Multiple test procedures other than Bonferroni's deserve wider use.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000167

7 January 2021

Hormones in the treatment of psychoses

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000167

7 January 2021

Is Oxytocin an Anti-Schizophrenic Hormone?

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000167

7 January 2021

Oxytocin as a natural antipsychotic: a study using oxytocin knockout mice

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000167

7 January 2021

Oxytocin receptor polymorphisms and adult attachment style in patients with depression

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000167

7 January 2021

Pedigree disequilibrium tests for multilocus haplotypes.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000167

7 January 2021

Oxytocin modulates psychotomimetic-induced deficits in sensorimotor gating

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000167

7 January 2021

Social amnesia in mice lacking the oxytocin gene.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000167

7 January 2021

Sample size requirements for association studies of gene-gene interaction

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000167

7 January 2021

Cerebrospinal fluid oxytocin concentration in schizophrenic patients does not differ from control subjects and is not changed by neuroleptic medication.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000167

7 January 2021

Diminished plasma oxytocin in schizophrenic patients with neuroendocrine dysfunction and emotional deficits

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000167

7 January 2021

Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000167

7 January 2021

Sharing secrets: oxytocin and trust in schizophrenia.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000167

7 January 2021

Social interaction deficits caused by chronic phencyclidine administration are reversed by oxytocin

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000167

7 January 2021

Apomorphine stimulation of vasopressin- and oxytocin-neurophysins. Evidence for increased oxytocinergic and decreased vasopressinergic function in schizophrenics

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000167

7 January 2021

Cerebrospinal fluid neurophysins in affective illness and in schizophrenia

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000167

7 January 2021

Adjusting for multiple testing in studies is less important than other concerns

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000167

7 January 2021

Clozapine, but not haloperidol, reverses social behavior deficit in mice during withdrawal from chronic phencyclidine treatment.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000167

7 January 2021

Association study of GSK3 gene polymorphisms with schizophrenia and clozapine response

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000167

7 January 2021

Genetic association of the GDNF alpha-receptor genes with schizophrenia and clozapine response.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000167

7 January 2021

Amperozide and clozapine but not haloperidol or raclopride increase the secretion of oxytocin in rats

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000167

7 January 2021

Positive association of the oxytocin receptor gene (OXTR) with autism in the Chinese Han population

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000167

7 January 2021

Genes controlling affiliative behavior as candidate genes for autism

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000167

7 January 2021

10.1017/S1461145710000167

Identifiers

DOI

1 reference

14 November 2017

1 reference